Medical News

RSS

ESC Congress 2011 to spotlight 'controversial issues in cardiology'

The scientific programme for this year's ESC Congress, which will take place in Paris from 27-31 August, is now complete and promises to provide journalists with a rich source of front-page news stories and background for topical features.

30 Jun 2011

GlobalPost examines GHI's work to address chronic malnutrition in Guatemala

Guatemala's "vast inequality" helped it land "on the list of eight 'plus' countries in the Global Health Initiative (GHI) that President Barack Obama is focusing on as part of his expansion and revision of how the U.S. is funding and rethinking global aid," GlobalPost's "Global Pulse" blog reports in an article examining malnutrition in Guatemala, the wealthiest of nations in the first round of GHI plus countries.

30 Jun 2011

NLST: CT screening reduces lung cancer specific mortality by 20%

Current and former heavy smokers can now be screened more effectively for lung cancer. Results from the National Lung Screening Trial (NLST) revealed that detecting small lung cancers with computed tomography (CT) reduces lung cancer specific mortality by 20 percent.

30 Jun 2011

Serum-free media with growth factors can improve MSCs' cell fate regulation

Mensenchymal stem cells (MSCs), multipotent cells identified in bone marrow and other tissues, have been shown to be therapeutically effective in the immunosuppression of T-cells, the regeneration of blood vessels, assisting in skin wound healing, and suppressing chronic airway inflammation in some asthma cases.

30 Jun 2011

Obstetricians/gynecologists rank Pfizer as No. 1 pharmaceutical company: SDI

According to SDI's Pharmaceutical Company Image 2011 study, obstetricians/gynecologists ranked Pfizer No. 1 overall. Forty percent of the 325 participating OB/GYNs reported that Pfizer was one of the three companies they held in highest esteem. In the 2010 study, Pfizer placed second.

30 Jun 2011

Drug companies collaborate with DNDi support to develop drug for African sleeping sickness

Researchers from Scynexis Inc. of Research Triangle Park, N.C., and Anacor Pharmaceuticals in Palo Alto, Calif., sponsored by the Drugs for Neglected Diseases initiative, on Tuesday reported in the journal PLoS Neglected Tropical Diseases that a new experimental drug kills the parasite that causes African sleeping sickness in mice and will enter human clinical trials this year, ScienceNOW reports.

30 Jun 2011

MR-guided focused ultrasound effective for treating essential tremor

The last ten years have been challenging for Billy R. Williams of Fort Valley, Virginia. The former Pentagon employee, who survived the 9/11 terrorist attack, has suffered from essential tremor, a progressive and debilitating neurological disorder.

30 Jun 2011

New technique can remove oil spill from soil

It is well known just how damaging oil can be to nature. It is also well known just how difficult it can be to clean up after a spill or contamination. Removing an oil spill or contamination from soil is hard and requires very different techniques to removing oil from water.

30 Jun 2011

Skanska secures SEK 1.3B to expand Nemours Children's Hospital in Delaware

Skanska has secured the assignment to construct the expansion of the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Delaware.

30 Jun 2011

Tips to stay healthy during vacation

Do you ever wonder why you feel so exhausted after returning from a vacation? The flights, car rides, hotel stays and on-the-go activities just might play a part in the way you feel. Dr. Marbella Zumaya, a physician with Covenant Medical Group, gives some tips on how to stay healthy while vacationing as well as how to come back feeling refreshed.

30 Jun 2011

N.C. Gov. Vetoes abortion bill; 2 Kansas doctors file suit against Kansas law; R.I. exchange bill caught in dispute

Gov. Bev Perdue vetoed a bill Monday that would require women seeking abortions to wait 24 hours after state-prescribed counseling, leaving the bill's House supporters looking for override votes. The bill would have made significant changes in state abortion policy, changes supporters said would give pregnant women important information about fetal development and abortion alternatives.

30 Jun 2011

Molecular radiotherapy offers hope for children with neuroblastoma

A new treatment option may soon be available for children with neuroblastoma according to research published in the July issue of The Journal of Nuclear Medicine.

30 Jun 2011

One-third of immigrant children, many foreign-born adults in N.J. lack health coverage

One-third of immigrant children and more than 70 percent of foreign-born, nonelderly adults living in New Jersey five years or less lack health coverage, a Rutgers statewide survey finds.

30 Jun 2011

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.

30 Jun 2011

Novartis reports NVA237 Phase III trial results against COPD

Sosei Group Corporation, announces that results reported today by Novartis from the pivotal Phase III GLOW2 clinical trial show that once-daily NVA237 50 mcg significantly improved lung function in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD) relative to placebo, with similar efficacy to open-label tiotropium.

30 Jun 2011

New technology reduces stress of scheduling chemotherapy treatments

The stress of scheduling chemotherapy treatments has been substantially reduced by a new technology created and implemented by a team of researchers from the Sauder School of Business at the University of British Columbia and the BC Cancer Agency.

30 Jun 2011

Valeant, Meda partner for life cycle opportunities for Elidel and Xerese

Meda and Valeant have entered into a collaboration agreement. Meda has out-licensed exclusive rights for Elidel and Xerese to Valeant for the U.S., Canada and Mexico. The parties will collaborate on life cycle opportunities for both products.

30 Jun 2011

Almirall, Forest Labs submit aclidinium bromide NDA to FDA for treatment of COPD

Forest Laboratories, Inc. and Almirall, S.A. announced they have recently submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for aclidinium bromide, a long-acting inhaled antimuscarinic agent developed for the treatment of COPD.

30 Jun 2011

Sensitivity of bladder cancer cells linked to chemotherapy and expression of miR-34a gene

Researchers at the UC Davis Cancer Center have discovered a way of sensitizing muscle-invasive bladder cancer cells so that they succumb to the toxic effects of chemotherapy. The finding adds to mounting evidence that tiny strands of RNA - called microRNA - play key roles in some of the deadliest types of cancer.

30 Jun 2011

Global Fund reports mid-year results

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday announced that programs it supports have distributed 190 million insecticide-treated bed nets to protect families from malaria since 2003, according to mid-year results, a Global Fund press release notes.

30 Jun 2011